Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

NCT04558034 is registered in ClinicalTrials.gov with Parkview Health as lead sponsor.

NCT NCT04558034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer
Lead sponsor
Parkview Health
Phase
Not applicable
Overall status
Terminated
Start date
August 4, 2020
Completion date
February 3, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryotherapy effect, nail toxicity, peripheral neuropathy